A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Conditions

Atopic Dermatitis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Naihui Zhou) · zhounaihui@163.com · 13328008259

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis Participants

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Shanghai, China · Shanghai, China

FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

Healthy Participants · Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Anaheim, United States · Miami, United States

A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis

Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

North Little Rock, United States · Camp Hill, United States

A Single and Multiple Ascending Dose Trial of LT-002-158 Tablets in Healthy Adult Volunteers

Healthy Volunteer · Hidradenitis Suppurativa · Atopic Dermatitis

Abroad (travel likely)RecruitingPHASE1

Shanghai, China